Evidence map›Paper›PMID 41097659›Full record

ReviewCancers2025

Application of Radiomics in Melanoma: A Systematic Review and Meta-Analysis.

Rosa Falcone, Sofia Verkhovskaia, Francesca Romana Di Pietro, Chiara Scianni, Giulia Poti, Maria Francesca Morelli, Paolo Marchetti, Federica De Galitiis, Matteo Sammarra, Armando Ugo Cavallo

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Rosa FalconeDepartment of Oncology, Istituto Dermopatico dell'Immacolata IDI-IRCCS, 00167 Rome, Italy.ORCID 0000-0001-9679-4711
Sofia VerkhovskaiaDepartment of Oncology, Istituto Dermopatico dell'Immacolata IDI-IRCCS, 00167 Rome, Italy.
Francesca Romana Di PietroDepartment of Oncology, Istituto Dermopatico dell'Immacolata IDI-IRCCS, 00167 Rome, Italy.ORCID 0000-0002-6779-8753
Chiara ScianniDepartment of Radiology, Istituto Dermopatico dell'Immacolata IDI-IRCCS, 00167 Rome, Italy.
Giulia PotiDepartment of Oncology, Istituto Dermopatico dell'Immacolata IDI-IRCCS, 00167 Rome, Italy.
Maria Francesca MorelliDepartment of Oncology, Istituto Dermopatico dell'Immacolata IDI-IRCCS, 00167 Rome, Italy.
Paolo MarchettiDepartment of Oncology, Istituto Dermopatico dell'Immacolata IDI-IRCCS, 00167 Rome, Italy.
Federica De GalitiisDepartment of Oncology, Istituto Dermopatico dell'Immacolata IDI-IRCCS, 00167 Rome, Italy.
Matteo SammarraDepartment of Radiology, Istituto Dermopatico dell'Immacolata IDI-IRCCS, 00167 Rome, Italy.
Armando Ugo CavalloDepartment of Radiology, Istituto Dermopatico dell'Immacolata IDI-IRCCS, 00167 Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

immunotherapymelanomameta-analysispredictiveradiomicstargeted therapy

Identifiers

PMID41097659
PMCPMC12524276

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.